The role of p38MAPK activation in spinal dorsal horn in remifentanil-induced postoperative hyperalgesia in rats.

Abstract

OBJECTIVES:

Remifentanil may induce hyperalgesia. Recent studies implicate a close relationship between post-surgical hyperalgesia and phosphorylation and activation of p38 mitogen-activated protein kinase (p38MAPK) in the spinal microglia. This study aimed to investigate whether the combination of post-surgical and remifentanil-induced hyperalgesia worsens post-operative pain and whether phosphorylated p38MAPK (phospho-p38MAPK) in the spinal dorsal horn in rats is involved in remifentanil-induced postoperative hyperalgesia.

METHODS:

Sprague-Dawley rats were randomly divided into six groups: control, incision only, remifentanil only, remifentanil + incision, remifentanil + incision + SB203580, and remifentanil + incision + DMSO. The p38MAPK inhibitor SB203580 and DMSO were injected intrathecally. A right plantar surgical incision was performed in the incision groups, and remifentanil was infused for 60 min in the remifentanil groups. Mechanical paw withdrawal threshold (PWT) and thermal paw withdrawal latency (PWL) of the bilateral hind paws were measured and the number of phospho-p38MAPK-positive cells in rat spinal dorsal horn sections was counted.

RESULTS:

Intravenous remifentanil infusion decreased bilateral plantar PWL values from 1 h to 3 days after surgery, however there was no additive effect with incision-induced values. There was a significant increase in the number of dorsal horn phospho-p38MAPK-positive cells in the remifentanil + incision group compared to the incision group, but no increase in the number of these cells when remifentanil was given alone. Intrathecal pretreatment with SB203580 attenuated remifentanil + incision-induced postoperative hyperalgesia and significantly reduced activation of phospho-p38MAPK in spinal dorsal horn.

CONCLUSIONS:

Incision-induced and remifentanil-induced increases in hyperalgesia were not additive when incision and remifentanil were used together. Data on phospho-38MAPK activation in remifenanil-induced hyperalgesia were contradictory and need further clarification.

• Authors: Liqin Deng, Lihua Zhang, Haiying Zhao, Fengxiang Song, Gang Chen, Hanyue Zhu
• Journal: Neurological research (Neurol Res) Vol. 38 Issue 10 Pg. 929-36 (Oct 2016) ISSN: 1743-1328 [Electronic] England
• PMID: 27687719 (Publication Type: Journal Article)

Chemical References

• Analgesics, Opioid
• Anti-Inflammatory Agents, Non-Steroidal
• Imidazoles
• Piperidines
• Pyridines
• p38 Mitogen-Activated Protein Kinases
• SB 203580
• Remifentanil

Topics

• Analgesics, Opioid (adverse effects)
• Analysis of Variance
• Animals
• Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
• Disease Models, Animal
• Enzyme Activation (drug effects)
• Hyperalgesia (chemically induced, pathology)
• Imidazoles (pharmacology)
• Male
• Pain Measurement
• Pain Threshold (drug effects)
• Pain, Postoperative (drug therapy)
• Piperidines (adverse effects)
• Pyridines (pharmacology)
• Rats
• Rats, Sprague-Dawley
• Remifentanil
• Spinal Cord Dorsal Horn (drug effects)
• Time Factors
• p38 Mitogen-Activated Protein Kinases (metabolism)